AndersonBrecon (UK) Limited (labeling and secondary packaging of medicinal product)

Ukraine

All drugs from this manufacturer

  • NAGLAZIM®

    The drug is used for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome).

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    galsulfase 1 mg/ml

    ATC: A16AB08